000 | 01172 a2200325 4500 | ||
---|---|---|---|
005 | 20250514210313.0 | ||
264 | 0 | _c20041202 | |
008 | 200412s 0 0 eng d | ||
022 | _a1420-682X | ||
024 | 7 |
_a10.1007/s00018-004-4257-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXiao, X | |
245 | 0 | 0 |
_aThe SARS-CoV S glycoprotein. _h[electronic resource] |
260 |
_bCellular and molecular life sciences : CMLS _cOct 2004 |
||
300 |
_a2428-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Fusion |
650 | 0 | 4 |
_aGlycoproteins _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Glycoproteins _xchemistry |
650 | 0 | 4 | _aProtein Structure, Tertiary |
650 | 0 | 4 |
_aSevere acute respiratory syndrome-related coronavirus _xmetabolism |
650 | 0 | 4 | _aSpike Glycoprotein, Coronavirus |
650 | 0 | 4 |
_aViral Envelope Proteins _xchemistry |
650 | 0 | 4 | _aViral Fusion Proteins |
700 | 1 | _aDimitrov, D S | |
773 | 0 |
_tCellular and molecular life sciences : CMLS _gvol. 61 _gno. 19-20 _gp. 2428-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00018-004-4257-y _zAvailable from publisher's website |
999 |
_c15213993 _d15213993 |